Why the study?
Are eNOS (Glu298Asp) and ApoE gene polymorphisms associated with an increased risk of coronary heart disease in Egyptians?
Are eNOS (Glu298Asp) and ApoE gene polymorphisms associated with an increased risk of coronary heart disease in Egyptians?
eNOS (Glu298Asp) and ApoE gene polymorphisms, particularly in combination, are significant genetic risk factors for coronary heart disease in the Egyptian population.
Answers are grounded in this paper and cite their sources.
Highlights potential novel genetic markers for CHD in Egyptians; leaves open their prognostic value pending validation.
In Egypt, The prevalence of chronic heart disease (CHD) is 8.3%. It is the principal cause of death and is responsible for 22% of total mortality. The age-adjusted mortality rate is 174 per 100,000 of population. There are many studies on traditional risk factors and CHD in Egypt but the study of novel risk factors is deficient. OBJECTIVES: (ApoE) gene polymorphism in a cohort of Egyptian individuals. METHODS: Genotyping of eNOS (Glu298Asp) and Apo E genes polymorphisms were done using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method for 100 CHD cases and 100 age and sex matched healthy controls. RESULTS: A statistically significant association was observed between GT and TT genotypes of endothelial nitric oxide synthase gene with CHD with OR = 2.03 and 3.5; respectively. Also, carriers of E4 allele and especially E3/E4 genotype were at higher risk of CHD with OR = 3.3 for both. Significant association was also observed between the presence of combined GTE3E4 genotype and CHD with OR = 6.6. CONCLUSION: GT and TT genotypes of endothelial nitric oxide synthase gene, E3/E4 genotype of Apo E gene polymorphism and combined GTE3E4 genotype can be considered risk factors for the development of CHD among Egyptians.
No takes yet. Share an insight, caveat, or question.
Arafa et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: